Olanzapine in the Treatment of Anorexia Nervosa

Completed · Phase 4 · Has a placebo group

Conditions studied: Anorexia Nervosa

In brief

This study compared 10 weeks of treatment with olanzapine versus placebo in adolescent females with anorexia nervosa-restricting type who were undergoing acute treatment on an inpatient unit or a day hospital program that specializes in the treatment of eating disorders.

Key facts

Study ID

NCT00592930

Run by

Northwell Health

People needed

20

Starts

2000-06-01

Expected to finish

2004-12-01

Last updated by the study team

2008-01-14

Who can join

Age: 12 and older, up to 23. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Females, ages 12-23

You may not qualify if…

• Binge-purge type

Where it is running

• Schneider Children's Hospital — New Hyde Park, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.